Status:

COMPLETED

A Randomized, Prospective, Double-Blind Study Comparing Fluconazole With Placebo for Primary and Secondary Prophylaxis of Mucosal Candidiasis in HIV-Infected Women

Lead Sponsor:

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborating Sponsors:

Pfizer

Conditions:

Candidiasis

Candidiasis, Esophageal

Eligibility:

FEMALE

13+ years

Phase:

NA

Brief Summary

To compare the efficacy of fluconazole versus placebo for the prevention of Candida esophagitis and vaginal/oropharyngeal candidiasis, including a comparison of the development of clinical resistance....

Detailed Description

Fluconazole has been shown to be effective in preventing or suppressing candidiasis in HIV-negative women. An increasing likelihood of oral and esophageal candidiasis in conjunction with progressive i...

Eligibility Criteria

Inclusion Criteria

Patients must have:

  • Evidence of HIV infection.
  • CD4+ count <= 300 cells/mm3 or <= 20 percent of total lymphocyte count.
  • Reasonably good health with a life expectancy of at least 6 months.
  • Pelvic exam including Pap smear or colposcopy performed within the past 90 days.

Prior Medication:

Allowed:

  • Topical or systemic treatment or prophylaxis with an antifungal agent.

Exclusion Criteria

Co-existing Condition:

Patients with the following symptoms and conditions are excluded:

  • Current diagnosis of Candida esophagitis.
  • Known intolerance to azoles.

Concurrent Medication:

Excluded:

  • Systemic treatment or prophylaxis with an antifungal agent.

Patients with the following prior conditions are excluded:

  • Past history of Candida esophagitis.

Key Trial Info

Start Date :

Trial Type :

INTERVENTIONAL

End Date :

December 1 1995

Estimated Enrollment :

400 Patients enrolled

Trial Details

Trial ID

NCT00000744

End Date

December 1 1995

Last Update

November 3 2021

Active Locations (16)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (16 locations)

1

Community Consortium of San Francisco

San Francisco, California, United States, 94110

2

Denver CPCRA / Denver Public Hlth

Denver, Colorado, United States, 80204

3

Wilmington Hosp / Med Ctr of Delaware

Wilmington, Delaware, United States, 19899

4

Veterans Administration Med Ctr / Regional AIDS Program

Washington D.C., District of Columbia, United States, 20422